Skip to main content
Search

The multidimensional landscape of pharmacovigilance: development and management

Part 2 of 2
Published on June 29, 2023   54 min

A selection of talks on Methods

Please wait while the transcript is being prepared...
0:00
Ladies and gentleman, welcome to Part 2 of my talk about the multidimensional landscape of pharmacovigilance. In the first part, I gave major arguments and reasons for introducing and practicing pharmacovigilance, and all about sciences and research which is needed in pharmacovigilance.
0:26
But that's not all. In this talk 2, I would like to address pharmaceutics and pharmaceutical sciences and its relationship to pharmacovigilance, and we'll address epidemiology and statistics and then give an explanation and understanding of risk and benefit of medicinal products. I will talk about living with uncertainty. Uncertainty is something that is frequent in sciences, but in pharmacovigilance, it has a greater importance. I will explain about law and legislation which is in the background of pharmacovigilance activities. I would make proposals for management in pharmacovigilance and what is needed, either in marketing authorization holders, equipment, or management agencies' environments. Who are the relevant stakeholders? It's a lot of different groups and people. I will come back to the issue of communication in pharmacovigilance. International cooperation is an important activity in pharmacovigilance. In the background, I will address some issues you probably will not bring in the context of pharmacovigilance.
Show
Hide

The multidimensional landscape of pharmacovigilance: development and management

Embed in course/own notes